ID

37291

Beschrijving

Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C; ODM derived from: https://clinicaltrials.gov/show/NCT02383940

Link

https://clinicaltrials.gov/show/NCT02383940

Trefwoorden

Versies (1)
  1. 14-07-19 14-07-19 -
Houder van rechten

See clinicaltrials.gov

Geüploaded op

14 juli 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Type 1 Diabetes Mellitus NCT02383940

Engels

Eligibility Type 1 Diabetes Mellitus NCT02383940

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
patient has given written informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
young adult patients ≥18 to ≤30 years old at screening, with a confirmed diagnosis of t1dm made at least 1 year prior to informed consent
Beschrijving

Adult | Age | Insulin-Dependent Diabetes Mellitus Disease length

Datatype

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C0011854
UMLS CUI [3,2]
C0872146
patients are being treated with insulin or insulin analogue delivered via csii or mdi
Beschrijving

Insulin | Insulin Analog | Continuous subcutaneous infusion of insulin | Insulin injection multiple daily

Datatype

boolean

Alias
UMLS CUI [1]
C0021641
UMLS CUI [2]
C2825028
UMLS CUI [3]
C0393124
UMLS CUI [4,1]
C0199782
UMLS CUI [4,2]
C0439064
UMLS CUI [4,3]
C0332173
at screening, must have a1c ≥9.0%
Beschrijving

Hemoglobin A1c measurement

Datatype

boolean

Alias
UMLS CUI [1]
C0474680
must be willing and able to perform smbg and complete the study diary
Beschrijving

Blood Glucose Self-Monitoring | Subject Diary Completion

Datatype

boolean

Alias
UMLS CUI [1]
C0005803
UMLS CUI [2,1]
C3890583
UMLS CUI [2,2]
C0205197
females of childbearing potential must use an adequate method of contraception and have a negative pregnancy test
Beschrijving

Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy test negative

Datatype

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0427780
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
any prior use of lx4211/sotagliflozin
Beschrijving

LX4211 | Sotagliflozin

Datatype

boolean

Alias
UMLS CUI [1]
C3502472
UMLS CUI [2]
C3502471
use of antidiabetic agent other than insulin or insulin analogue at the time of screening
Beschrijving

Antidiabetics | Exception Insulin | Exception Insulin Analogue

Datatype

boolean

Alias
UMLS CUI [1]
C0935929
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0021641
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C2825028
use of sglt inhibitors within 8 weeks prior to start of the placebo run-in period
Beschrijving

Sodium-Glucose Transporter Inhibitors

Datatype

boolean

Alias
UMLS CUI [1]
C3665045
chronic systemic corticosteroid use
Beschrijving

Corticosteroids for systemic use chronic

Datatype

boolean

Alias
UMLS CUI [1,1]
C3653708
UMLS CUI [1,2]
C0205191
type 2 diabetes, or severely uncontrolled diabetes mellitus as determined by the investigator
Beschrijving

Diabetes Mellitus, Non-Insulin-Dependent | Diabetes mellitus uncontrolled Severe

Datatype

boolean

Alias
UMLS CUI [1]
C0011860
UMLS CUI [2,1]
C0421258
UMLS CUI [2,2]
C0205082
history of dka or nonketotic hyperosmolar state within 6 months prior to the screening visit
Beschrijving

Diabetic Ketoacidosis | Diabetic hyperosmolar non-ketotic state

Datatype

boolean

Alias
UMLS CUI [1]
C0011880
UMLS CUI [2]
C0553772
history of severe hypoglycemic event within 1 month prior to screening visit
Beschrijving

Hypoglycemia Event Severe

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0441471
UMLS CUI [1,3]
C0205082
Terug naar het begin van de pagina

Similar models

Eligibility Type 1 Diabetes Mellitus NCT02383940

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
patient has given written informed consent
boolean
C0021430 (UMLS CUI [1])
Adult | Age | Insulin-Dependent Diabetes Mellitus Disease length
Item
young adult patients ≥18 to ≤30 years old at screening, with a confirmed diagnosis of t1dm made at least 1 year prior to informed consent
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0011854 (UMLS CUI [3,1])
C0872146 (UMLS CUI [3,2])
Insulin | Insulin Analog | Continuous subcutaneous infusion of insulin | Insulin injection multiple daily
Item
patients are being treated with insulin or insulin analogue delivered via csii or mdi
boolean
C0021641 (UMLS CUI [1])
C2825028 (UMLS CUI [2])
C0393124 (UMLS CUI [3])
C0199782 (UMLS CUI [4,1])
C0439064 (UMLS CUI [4,2])
C0332173 (UMLS CUI [4,3])
Hemoglobin A1c measurement
Item
at screening, must have a1c ≥9.0%
boolean
C0474680 (UMLS CUI [1])
Blood Glucose Self-Monitoring | Subject Diary Completion
Item
must be willing and able to perform smbg and complete the study diary
boolean
C0005803 (UMLS CUI [1])
C3890583 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Childbearing Potential Contraceptive methods | Childbearing Potential Pregnancy test negative
Item
females of childbearing potential must use an adequate method of contraception and have a negative pregnancy test
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C3831118 (UMLS CUI [2,1])
C0427780 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
LX4211 | Sotagliflozin
Item
any prior use of lx4211/sotagliflozin
boolean
C3502472 (UMLS CUI [1])
C3502471 (UMLS CUI [2])
Antidiabetics | Exception Insulin | Exception Insulin Analogue
Item
use of antidiabetic agent other than insulin or insulin analogue at the time of screening
boolean
C0935929 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0021641 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C2825028 (UMLS CUI [3,2])
Sodium-Glucose Transporter Inhibitors
Item
use of sglt inhibitors within 8 weeks prior to start of the placebo run-in period
boolean
C3665045 (UMLS CUI [1])
Corticosteroids for systemic use chronic
Item
chronic systemic corticosteroid use
boolean
C3653708 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Diabetes Mellitus, Non-Insulin-Dependent | Diabetes mellitus uncontrolled Severe
Item
type 2 diabetes, or severely uncontrolled diabetes mellitus as determined by the investigator
boolean
C0011860 (UMLS CUI [1])
C0421258 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Diabetic Ketoacidosis | Diabetic hyperosmolar non-ketotic state
Item
history of dka or nonketotic hyperosmolar state within 6 months prior to the screening visit
boolean
C0011880 (UMLS CUI [1])
C0553772 (UMLS CUI [2])
Hypoglycemia Event Severe
Item
history of severe hypoglycemic event within 1 month prior to screening visit
boolean
C0020615 (UMLS CUI [1,1])
C0441471 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial